{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 406013269
| IUPAC_name = (''S'')-''N''-<nowiki>[[</nowiki>3-[3-Fluoro-4-[4-(2-hydroxyacetyl)piperazin-<br/>1-yl]phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide
| image = Eperezolid.png
| alt = Skeletal formula of eperezolid
| width = 260
| image2 = Eperezolid 3D spacefill.png
| alt2 = Space-filling model of the eperezolid molecule

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 165800-04-4
| ATC_prefix = none
| ATC_suffix =  
| PubChem = 73214
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = C460ZSU1OW
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D04017
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 47955
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 65969

<!--Chemical data-->
| C=18 | H=23 | F=1 | N=4 | O=5 
| molecular_weight = 394.40
| smiles = CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCN(CC3)C(=O)CO)F
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C18H23FN4O5/c1-12(25)20-9-14-10-23(18(27)28-14)13-2-3-16(15(19)8-13)21-4-6-22(7-5-21)17(26)11-24/h2-3,8,14,24H,4-7,9-11H2,1H3,(H,20,25)/t14-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = SIMWTRCFFSTNMG-AWEZNQCLSA-N

}}

'''Eperezolid''' is an [[oxazolidinone]] [[antibiotic]].

==Synthesis==
[[File:Eperezolid synthesis.png|thumb|center|600px|Eperezolid synthesis <ref>{{Cite journal | doi = 10.1021/jm9509556| title = Synthesis and Antibacterial Activity of U-100592 and U-100766, Two Oxazolidinone Antibacterial Agents for the Potential Treatment of Multidrug-Resistant Gram-Positive Bacterial Infections| journal = Journal of Medicinal Chemistry| volume = 39| issue = 3| pages = 673â€“9| year = 1996| last1 = Brickner | first1 = S. J. | last2 = Hutchinson | first2 = D. K. | last3 = Barbachyn | first3 = M. R. | last4 = Manninen | first4 = P. R. | last5 = Ulanowicz | first5 = D. A. | last6 = Garmon | first6 = S. A. | last7 = Grega | first7 = K. C. | last8 = Hendges | first8 = S. K. | last9 = Toops | first9 = D. S. | last10 = Ford | first10 = C. W. | last11 = Zurenko | first11 = G. E. | pmid=8576909}}</ref>]]

==See also==
[[Linezolid]]

==References==
{{Reflist}}
{{Protein synthesis inhibitor antibiotics}}

[[Category:Oxazolidinone antibiotics]]
[[Category:Acetamides]]
[[Category:Fluoroarenes]]
[[Category:Piperazines]]
[[Category:Alcohols]]


{{antibiotic-stub}}